State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07009288 N/A
Recruiting
A Study of Time-Restricted Eating in Childhood Cancer Survivors
Condition
Childhood Cancer Survivors
Enrollment
300 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06573294 Phase 1
Recruiting
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid ...
Condition
Advanced Malignant Solid Tumors
Enrollment
45 pts
Location
United States, Japan, Spain
Sponsor
Genmab
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT04468061 Phase 2
Recruiting
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Condition
Breast Cancer
Enrollment
110 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05783323 Phase 2
Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Condition
Differentiated Thyroid Cancer
Enrollment
13 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT07221474 Phase 2
Recruiting
A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous ...
Condition
Squamous Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT07048535 N/A
Recruiting
CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions
Condition
B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Enrollment
80 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05634369 Phase 1, Phase 2
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK...
Condition
Pediatric Sarcoma, Refractory
Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06440005 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in P...
Condition
Cancer
Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07006792 Phase 4
Recruiting
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Modera...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06915454 N/A
Recruiting
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Condition
Cancer
Enrollment
50 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente
NCT05194397 Phase 2
Recruiting
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Sur...
Condition
Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT05028205 N/A
Recruiting
EBT Fruit and Vegetable Prescription
Condition
Childhood Obesity
Enrollment
30 pts
Location
United States
Sponsor
The University of Tennessee, K
NCT06088290 Phase 3
Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone ...
Condition
Leiomyosarcoma
Enrollment
450 pts
Location
United States, Austria, Belgium
Sponsor
PharmaMar
NCT06526819 Phase 1, Phase 2
Recruiting
SMP-3124LP in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
120 pts
Location
United States, Japan
Sponsor
Sumitomo Pharma America, Inc.